Recruiting NA INTERVENTIONAL 2-arm NCT03504956

Coronary Atherosclerosis T1-Weighted Characterization (CATCH) (CATCH)

Sponsor: Cedars-Sinai Medical Center

Interventions Beta blocker Cardiac MRI Contrast

Updated 12 times since 2018 Last updated: Aug 11, 2025 Started: Jul 30, 2018 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03504956, this NA trial focuses on Coronary Atherosclerosis and remains actively recruiting participants. Sponsored by Cedars-Sinai Medical Center, it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Recruiting NA
Aug 2023 — Apr 2024 [monthly]

Recruiting NA

▶ Show 7 earlier versions

Sep 2022 — Aug 2023 [monthly]

Recruiting NA
Sep 2021 — Sep 2022 [monthly]

Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA
Jul 2019 — Jul 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Jul 2019 [monthly]

Not Yet Recruiting NA
May 2018 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cedars-Sinai Medical Center

Data source: Cedars-Sinai Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States